For example, we and others have demonstrated that MYC expression is elevated in the estrogen, progesterone and human epidermal growth factor receptor-2 (HER2), receptor triple-negative subtype of breast cancer (TNBC; Horiuchi et al., 2012; Koboldt et al., 2012). The gene discussed is ERBB2; the disease is breast cancer.